Adenosine A1 receptor blockade mimics caffeine's attenuation of ethanol-induced motor incoordination

Basic and Clinical Pharmacology and Toxicology

Volumn 95, Issue 6, 2004, Pages 299-304

  Connole, Laura ^a   Harkin, Andrew ^b   Maginn, Mark ^a  

^a H LUNDBECK A S   (Denmark)

^b UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

5 AMINO 2 (2 FURYL) 7 (2 PHENYLETHYL)PYRAZOLO[4,3 E][1,2,4]TRIAZOLO[1,5 C]PYRIMIDINE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE A1 RECEPTOR ANTAGONIST; ADENOSINE A2A RECEPTOR ANTAGONIST; ADENOSINE RECEPTOR BLOCKING AGENT; ALCOHOL; CAFFEINE; 1,3-DIPROPYL-8-CYCLOPENTYLXANTHINE; ADENOSINE A1 RECEPTOR; ADENOSINE RECEPTOR; CENTRAL DEPRESSANT AGENT; PYRIMIDINE DERIVATIVE; TRIAZOLE DERIVATIVE; XANTHINE DERIVATIVE;

ALCOHOL CONSUMPTION; ALCOHOL INTOXICATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; MALE; MOTOR COORDINATION; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; TASK PERFORMANCE; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; DRUG INTERACTION; SPRAGUE DAWLEY RAT;

ANIMALIA;

ANIMALS; CAFFEINE; CENTRAL NERVOUS SYSTEM DEPRESSANTS; DRUG INTERACTIONS; ETHANOL; MALE; MOTOR SKILLS; PYRIMIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ADENOSINE A1; RECEPTORS, PURINERGIC P1; TRIAZOLES; XANTHINES;

EID: 10644243464     PISSN: 17427835     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2004.pto950509.x     Document Type: Article

References (38)

1. Barwick, V. S. & S. Dar: Adenosinergic modulation of ethanol-induced motor in-coordination in the rat motor cortex. Prog. Neuropsychopharmacol. Biol. Psychiatry 1998, 22, 587-607.
2. Baumgold, J., O. Nikodijevic & K. A. Jacobson: Penetration of adenosine antagonists into mouse brain as determined by ex vivo binding. Biochem. Pharmacol. 1992, 43, 889-894.
3. Bogo, V., T. A. Hill & R. W. Young: Comparison of accelerod and rotarod sensitivity in detecing ethanol- and acrylamide-induced performance decrement in rats: Review of experimental considerations of rotating rod systems. Neurotoxicol. 1981, 2, 765-787.
4. Clark, M. & M. S. Dar: Mediation of acute ethanol-induced motor disturbance by cerebellar adenosine in rats. Pharmacol. Biochem. Behav. 1988, 30, 155-161.
5. 3H] adenosine by rat cerebellar synaptosomes. Alcohol. Clin. Exp. Res. 1989a, 13, 371-377.
6. Clark, M. & M. S. Dar: Release of endogenous glutamate from rat cerebellar synaptosomes: Interactions with adenosine and ethanol. Pharmacol. Biochem. Behav. 1989b, 30, 155-161.
7. Dar, M. S.: The biphasic effects of centrally and peripherally administered caffeine on acute ethanol-induced MI in mice. J. Pharm. Pharmacol. 1988, 40, 482-487.
8. Dar, M. S.: Functional correlation between subclasses of brain adenosine receptor affinities and ethanol-induced motor incoordination in mice. Pharmacol. Biochem. Behav. 1990, 37, 747-753.
9. Dar, M. S.: Mouse cerebellar adenosinergic modulation of ethanol-induced motor in-coordination: possible involvement of cAMP. Brain Res. 1997, 749, 263-274.
10. 1 adenosinergic receptor. Brain Res. Bull. 2001, 55, 513-520.
11. Dar, M., E. Bowman & C. Li: Intracerebellar nicotinic-cholinergic participation in the cerebellar adenosinergic modulation of ethanol-induced motor in-coordination in mice. Brain Res. 1994, 644, 117-127.
12. A receptors in mediating the effects of alcohol in the central nervous system. J. Psychiatry Neurosci. 2003, 28, 263-274 (review).
13. Dunwiddie, T. V. & S. A. Masino: The role and regulation of adenosine in the central nervous system. Ann. Rev. Neurosci. 2001, 24, 31-35.
14. 2A receptors. Brit. J. Pharmacol. 2000a, 129, 1465-1473.
15. 2A receptor. Eur. J. Pharmacol. 2000b, 401, 63-77.
16. 2A receptor blockade. Neuropharmacol. 2003, 45, 977-985.
17. 2A receptor antagonism potentiates L-DOPA-induced turning behaviour and c-fos expression in 6-hydroxydopamine-lesioned rats. Eur. J. Pharmacol. 1997, 321, 143-147.
18. Fredholm, B. B.: Adenosine, adenosine receptors and the actions of caffeine. Pharmacology & Toxicology 1995, 76, 93-101.
19. Fredholm, B. B., K. Battig, J. Holmen, A. Nehlig & E. E. Zvartau: Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol. Rev. 1999, 51, 83-133.
20. Holzman, S. G.: CGS 15943, a non xanthine adenosine receptor antagonist: effects on locomotor activity of non-tolerant and caffeine-tolerant rats. Life Sci. 1991, 49, 1563-1570.
21. Jacobson, K. A., D. K. von Lubitz, J. W. Daly & B. B Fredholm: Adenosine receptor ligands: differences with acute versus chronic treatment. Trends Pharmacol. Sci. 1996, 17, 108-13.
22. Jacobson, K. A. & A. M. van Rhee: Development of selective purinoceptor agonists and antagonists. In: Purinergic approaches in experimental therapeutics. Eds.: K. A. Jacobson & M. E Jarvis. Wiley-Liss, New York, 1997, pp. 101-128.
23. 1 adenosine receptor occupancy. Neuropsychophamacol. 1992, 6, 145-153.
24. 2A receptors in the motor effects of caffeine after its acute and chronic administration. Neuropsychopharmacol. 2003, 28, 1281-91.
25. Krystal, J. H., I. L. Petrakis, G. Mason, L. Trevisan & D. S. D'Souza: N-methyl-D-aspartate glutamate receptors and alcoholism: reward, dependence, treatment and vulnerability. Pharmacol. Therap. 2003, 99, 79-94.
26. 2A receptor. Nature 1997, 388, 674-678.
27. Malliard, W. S. & I. Diamond: Recent advances in the neurobiology of alcoholism: the role of adenosine. Pharmacol. Therap. 2004, 101, 39-46.
28. 1 receptors using in vivo and in vitro techniques. J. Pharmacol. Exp. Therap. 1998, 285, 1023-1030.
29. Meng, Z. H. & M. S. Dar: Possible role of striatal adenosine in the modulation of acute ethanol-induced motor incoordination in rats. Alcohol Clin. Exp. Res. 1995, 19, 892-901.
30. 2A receptors by SCH 58261 results in neuroprotective effects in cerebral ischemia in rats. Neuroreport 1998, 9, 3955-3959.
31. 2A receptors: an overview. Brain Res. Rev. 1999, 31, 65-82.
32. Nehlig, A., J. L. Daval & G. Debry: Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effect. Brain Res. Rev. 1992, 17, 139-170.
33. Nikodijevic, O. & K. A. Jacobson: Locomotor activity in mice during chronic treatment with caffeine and withdrawal. Pharmacol. Biochem. Behav. 1993, 45, 1003.
34. 2A adenosine receptor antagonist. Drug Dev. Res. 1997, 42, 63-70.
35. Ongini, E., S. Dionisotti, S. Gessi, E. Irenius & B. B. Fredhohn: Comparison of CGS 15943, ZM241385 and SCH 58261 as antagonists at human adenosine receptors. Naunyn-Schmiedebergs Arch. Pharmacol. 1999, 359, 7-10.
36. Ribeiro, J. A., A. M. Sebastiao & A. de Mendonca: Adenosine receptors in the nervous system: pathophysiological implications. Prog. Neurobiol. 2003, 68, 377-392.
37. Snyder, S. H., J. J. Katims, Z. Annau, R. F. Bruns & J. W. Daly: Adenosine receptors and behavioral actions of methylxanthines. Proc. Natl. Acad. Sci. USA 1981, 78, 3260-3264.
38. Svenningsson, P., G. G. Nomikos & B. B. Fredholm: Biphasic changes in locomotor behaviour and in expression of mRNA for NGFI-A and NGFI-B in rat striatum following acute caffeine administration. J. Neurosci. 1995, 15, 7612-7624.